Science
Mechanism of Action
Harpagide is understood to exert its effects by modulating the arachidonic acid pathway, a key mediator of inflammation. Specifically, it has been reported to inhibit the synthesis of pro-inflammatory mediators, including the suppression of cyclooxygenase-2 (COX-2) enzymes and their product prostaglandin E2 (PGE-2). Beyond its anti-inflammatory actions, Harpagide also demonstrates antioxidant capabilities. Interestingly, hydrolyzed forms of harpagide have shown enhanced anti-inflammatory activity compared to their unhydrolyzed counterparts. However, studies on ex vivo porcine skin have presented contradictory findings: while a complete *Harpagophytum procumbens* extract (containing harpagide) effectively inhibited COX-2 and PGE-2 expression, isolated harpagide applied topically led to a significant increase in COX-2 expression after 6 hours.
Research
Clinical Evidence
Low confidenceN/A
Key findings
- 01 An *Harpagophytum procumbens* extract, containing harpagide, demonstrated inhibition of cyclooxygenase-2 (COX-2) and prostaglandin E2 (PGE-2) expression after transcutaneous delivery. The harpagide concentration in the receptor phase reached 25 micromol mL-1.
- 02 Topical application of isolated Harpagide caused a significant increase in COX-2 expression after 6 hours.
Transparency
Dusting Analysis
No specific data is available to assess the dusting potential of Harpagide in cosmetic formulations.
The Formula
Formulation
Stability
The anti-inflammatory efficacy of harpagide is noted to be more pronounced in its hydrolyzed forms. Formulators might consider strategies to promote hydrolysis or utilize pre-hydrolyzed derivatives for enhanced activity. Ethanol is suggested as an unsuitable vehicle for *Harpagophytum procumbens* extracts containing harpagide, as it may enhance penetration in a manner that could potentially diminish the anti-inflammatory activity of other co-occurring compounds within the extract.
Synergies
- Hydrolyzed forms of harpagide for potentially enhanced anti-inflammatory activity.
Conflicts
- Ethanol as a vehicle for Harpagophytum procumbens extracts containing harpagide, as it may counteract overall anti-inflammatory activity.
Safety
Safety Profile
Harpagide has not undergone specific review by the Cosmetic Ingredient Review (CIR) Expert Panel or the Scientific Committee on Consumer Safety (SCCS) for cosmetic applications. While registered with the FDA Global Substance Registration System (GSRS), this registration does not imply a 'safe as used' status for cosmetics. The European Chemicals Agency (ECHA) lists an oral toxicity classification ('Acute Tox. 4: Harmful if swallowed'), but this pertains to ingestion and does not directly inform topical cosmetic safety.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Due to directly conflicting ex vivo data where isolated Harpagide increased COX-2 expression (in contrast to the inhibitory effect of whole extracts), coupled with the absence of specific cosmetic topical safety reviews, its utility as a precision topical ingredient is questionable without further dedicated research clarifying its precise epidermal actions.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources